DekaBank Deutsche Girozentrale - RELAY THERAPEUTICS INC ownership

RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 140 filers reported holding RELAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of RELAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$494
-35.7%
60,0000.0%0.00%
-50.0%
Q2 2023$768
-19.6%
60,0000.0%0.00%0.0%
Q1 2023$955
+114.6%
60,000
+99.3%
0.00%
+100.0%
Q4 2022$445
-99.9%
30,1000.0%0.00%
-50.0%
Q3 2022$704,000
+39.4%
30,1000.0%0.00%
+100.0%
Q2 2022$505,000
-45.3%
30,1000.0%0.00%
-50.0%
Q1 2022$923,000
+0.5%
30,100
-1.0%
0.00%0.0%
Q4 2021$918,000
-7.5%
30,400
+2.4%
0.00%
-33.3%
Q3 2021$992,000
-10.5%
29,7000.0%0.00%0.0%
Q2 2021$1,108,000
+4.8%
29,7000.0%0.00%
-25.0%
Q1 2021$1,057,000
-6.6%
29,700
+11.2%
0.00%0.0%
Q4 2020$1,132,00026,7000.00%
Other shareholders
RELAY THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BVF INC/IL 4,530,605$135,601,0005.42%
Casdin Capital, LLC 3,857,253$115,448,0005.18%
Boxer Capital, LLC 2,669,132$79,887,0004.11%
Nextech Invest Ltd. 475,485$14,231,0004.06%
SB INVESTMENT ADVISERS (UK) LTD 27,904,963$835,196,0003.96%
Integral Health Asset Management, LLC 327,000$9,787,0002.55%
EcoR1 Capital, LLC 2,291,441$68,583,0002.14%
Fernwood Investment Management, LLC 185,063$5,539,0001.94%
HARBOURVEST PARTNERS LLC 296,402$8,871,0001.81%
HARVARD MANAGEMENT CO INC 541,124$16,196,0001.64%
View complete list of RELAY THERAPEUTICS INC shareholders